Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 52

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 52
---
4United StatesInternationalTotalUnited StatesInternationalTotalConsumables and parts revenue$6,686 $6 $6,692 $4,920 $31 $4,951 System revenue3,445 - 3,445 2,112 - 2,112 License fees and other- 10 10 - 15 15 Product Revenue$10,131 $16 $10,147 $7,032 $46 $7,078 Rental Income17 - 17 84 - 84 Total Revenue$10,148 $16 $10,164 $7,116 $46 $7,162 Six Months Ended June 30, 2025Six Months Ended June 30, 2024United StatesInternationalTotalUnited StatesInternationalTotalConsumables and parts revenue$12,764 $16 $12,780 $9,161 $97 $9,258 System revenue6,643 - 6,643 3,413 71 3,484 License fees and other- 15 15 - 20 20 Product Revenue$19,407 $31 $19,438 $12,574 $188 $12,762 Rental Income68 - 68 186 - 186 Total Revenue$19,475 $31 $19,506 $12,760 $188 $12,948 

13.        Stock-Based Compensation

On August 7, 2024, the stockholders of the Company approved the 2024 Equity Incentive Plan (the “2024 Plan”). The 2024 Plan authorizes the issuance of up to 1,376,556 shares of common stock. Stock options granted under the 2024 Plan include service-based, performance-based, and market-based awards. Service-based stock options generally vest over a three-year period, expire 10 years from the date of grant, and are forfeited upon separation from the Company. Performance-based stock options vest upon the achievement of pre-established financial or operational performance criteria, as determined by the Company’s Board of Directors or Compensation Committee. These awards generally expire five years from the date of grant and are subject to forfeiture if the performance goals are not achieved within the specified performance period. Market-based stock options vest upon the attainment of certain market conditions, such as specified 

18